Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.56 USD | -1.51% | -12.98% | +8.06% |
Apr. 22 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
Apr. 22 | U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents | RE |
Financials (USD)
Sales 2022 | 254M | Sales 2023 | 193M | Capitalization | 243M |
---|---|---|---|---|---|
Net income 2022 | 6M | Net income 2023 | 2M | EV / Sales 2022 | -0.15 x |
Net cash position 2022 | 456M | Net cash position 2023 | 379M | EV / Sales 2023 | -0.71 x |
P/E ratio 2022 |
67.2
x | P/E ratio 2023 |
106
x | Employees | 203 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.79% |
Latest transcript on Vanda Pharmaceuticals Inc.
1 day | -1.51% | ||
1 week | -12.98% | ||
Current month | +10.95% | ||
1 month | +17.22% | ||
3 months | +24.25% | ||
6 months | +8.06% | ||
Current year | +8.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 02-10-31 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 12-11-30 |
Scott Howell
HRO | Human Resources Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 05-11-30 |
Chief Executive Officer | 64 | 02-10-31 | |
Director/Board Member | 72 | 20-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.34% | 29 M€ | -3.64% | ||
0.22% | 27 M€ | -4.43% | - | |
0.05% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4.56 | -1.51% | 1,458,632 |
24-04-23 | 4.63 | -3.54% | 1,371,417 |
24-04-22 | 4.8 | -6.07% | 2,114,924 |
24-04-19 | 5.11 | +2.82% | 2,440,757 |
24-04-18 | 4.97 | -5.15% | 3,859,528 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+8.06% | 262M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.75% | 22.2B | |
-16.53% | 21.23B | |
-8.93% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- VNDA Stock